In this study we have analyzed 100 people. 40 patients and 60 control group had sleep disturbances. The genes SCN1A, SCN2A, EPM2A analyzed in terms of genetic mutations made. In this study, people who have genetic mutations were targeted, with dravet syndrome nervous disorders, seizure or epilepsy. In fact, of all people with seizure or epilepsy, 40 people had a genetic mutation in the genes SCN1A, SCN2A, EPM2A. Any genetic mutations in the target genes control group, did not show.